GlassScriptPhysician profile
Alexander Dees
NPI 1598309403
$21,172.43
in general payments reported to CMS, 2019-2025
17 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,006 · 2022: $370 · 2023: $1,654 · 2024: $2,600 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $3,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,460.87 |
| Food and Beverage | $3,335.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $19,008.49 | 2022-2025 | Stratafix, Vistaseal, Orthovisc |
| Stryker Corporation | $1,025.59 | 2021-2022 | |
| Ethicon US, LLC | $223.95 | 2022-2025 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Medtronic, INC. | $203.67 | 2021-2024 | Closurefast, Intellis Adaptivestim, Stealthstation S8 Platform |
| Depuy Synthes Sales INC. | $172.54 | 2022-2024 | Teligen, Orthovisc, Monovisc |
| Davol INC. | $121.94 | 2025 | Arista |
| Orthofix Medical, INC. | $94.99 | 2022-2025 | Spinal-Stim, Spinal-Stim |
| Bioventus LLC | $59.72 | 2021-2022 | |
| Relievant Medsystems, INC. | $44.95 | 2022-2023 | Intracept |
| Cerapedics INC. | $42.23 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Smith+Nephew, INC. | $39.01 | 2024-2025 | Pico 14, Renasys Touch, "Acticoat 4"" X 4""" |
| Pacira Pharmaceuticals Incorporated | $30.24 | 2024-2025 | Iovera, Exparel, Zilretta |
| Reel Surgical, INC. | $26.30 | 2024 | |
| Abbvie INC. | $25.27 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.81 | 2024 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $14.68 | 2025 | Activ.A.C., 3m Cavilon, Promogran Prisma |
| Kowa Pharmaceuticals America, INC. | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Dees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.